Sintx Technologies (SINT) Gross Margin Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 63.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -136.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -324.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 311.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 56.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -164.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 124.00 |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 | -4,021.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,021.00 |
| Dec 31, 2025 | -3,125.00 |
| Sep 30, 2025 | -3,440.00 |
| Jun 30, 2025 | -3,475.00 |
| Mar 31, 2025 | -465.00 |
| Dec 31, 2024 | 4,734.00 |
| Sep 30, 2024 | 5,322.00 |
| Jun 30, 2024 | 4,620.00 |
| Mar 31, 2024 | 2,794.00 |
| Dec 31, 2023 | 3,084.00 |
| Sep 30, 2023 | 6,305.00 |
| Jun 30, 2023 | 5,943.00 |
| Mar 31, 2023 | 5,830.00 |
| Dec 31, 2022 | 7,028.00 |
| Sep 30, 2022 | 6,639.00 |
| Jun 30, 2022 | 5,214.00 |
| Mar 31, 2022 | 1,943.00 |
| Jun 30, 2021 | -4,673.00 |
| Mar 31, 2021 | -3,752.00 |
| Dec 31, 2020 | 6,609.00 |
| Sep 30, 2020 | -3,267.00 |
| Jun 30, 2020 | -5,740.00 |
| Mar 31, 2020 | -5,505.00 |
| Dec 31, 2019 | -4,403.00 |
| Sep 30, 2019 | -6,464.00 |
| Jun 30, 2019 | -5,436.00 |
| Mar 31, 2019 | -6,004.00 |
| Jun 30, 2018 | 296.00 |
| Mar 31, 2018 | 922.00 |
| Dec 31, 2017 | -9,348.00 |
| Sep 30, 2017 | -1,530.00 |
| Jun 30, 2017 | 496.00 |
| Mar 31, 2017 | 339.00 |
| Dec 31, 2016 | 16,898.00 |
| Sep 30, 2016 | 1,014.00 |
| Jun 30, 2016 | -332.00 |
| Mar 31, 2016 | 556.00 |